Biohaven Pharmaceuticals, Inc.
Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.
-
Hope for ataxia: new pill aims to slow worsening of balance and speech
Disease control OngoingThis study tests whether a daily pill called troriluzole can help adults with spinocerebellar ataxia, a rare brain disease that affects balance, walking, and speech. About 300 participants took either the drug or a placebo for 48 weeks. The main goal was to see if the drug slows …
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy. About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The goal is to see if the…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC